Sign in
4

Changes in Ownership

Larimar Therapeutics, Inc. Filed Acc 0000899243-17-013254

President and CEO acquired 93,211 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hughes Thomas E. President and CEO 2017-05-11 Option exercise +18,928 $0.75 $14,196 83,088 D: show line 1 in the form
Hughes Thomas E. President and CEO 2017-05-11 Option exercise +6,210 $0.75 $4,658 89,298 D: show line 2 in the form
Hughes Thomas E. President and CEO 2017-05-11 Option exercise +68,073 $0.82 $55,820 157,371 D: show line 3 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hughes Thomas E. President and CEO 2017-05-11 Option exercise · Stock Option (Right to Buy −18,928 0 D: show line 4 in the form
Hughes Thomas E. President and CEO 2017-05-11 Option exercise · Stock Option (Right to Buy) −6,210 0 D: show line 5 in the form
Hughes Thomas E. President and CEO 2017-05-11 Option exercise · Stock Option (Right to Buy) −68,073 0 D: show line 6 in the form
Loading xslF345X03/doc4.xml…